Oxygen Reserve Index Validation for RD Lite Sensors

NCT03128892 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-03-01

Study results available
· View outcomes & findings →

Summary

Oxygen Reserve Index (ORI) is a parameter that provides information on arterial partial pressure of oxygen (PaO2). In this study, the PaO2 is varied by controlling the concentration of oxygen the study volunteer breathes. The ORI device measurement is analyzed by comparing it to the PaO2 measurements from a laboratory analyzer.

Conditions

  • Healthy

Interventions

DEVICE

Oxygen Reserve Index - RD Lite Sensors

Sponsors & Collaborators

  • Masimo Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-10
Primary Completion
2017-03-29
Completion
2017-03-29

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03128892 on ClinicalTrials.gov